Technical Analysis for ICAD - icad inc.

Grade Last Price % Change Price Change
grade D 10.4 -0.76% -0.08
ICAD closed down 0.76 percent on Friday, August 7, 2020, on 54 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Up
Historical ICAD trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Crossed Above 50 DMA Bullish -0.76%
Bollinger Band Squeeze Range Contraction -0.76%
BB Squeeze Started Range Contraction -0.76%
Inside Day Range Contraction -0.76%
50 DMA Resistance Bearish 0.68%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.68%
Crossed Above 20 DMA Bullish 0.68%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy that enable healthcare professionals and radiologists to identify pathologies and pinpoint cancer earlier. It offers Axxent eBx system, which is used for the treatment of early stage breast cancer, endometrial cancer, and skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated. It also provides computer-aided detection (CAD) solutions for digital and film-based mammography systems, including SecondLook systems that detects and identifies masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer's network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to PACS and/or review workstations. In addition, the company offers image analysis and workflow solutions in MRI imaging comprising SpectraLook for breast, VividLook for prostate, and OmniLook for other organs; and VersaVue Enterprise, a review and reporting solution, which provides visual and quantitative depictions of the movement of contrast agent through a lesion. Further, it provides VeraLook that supports the detection of colonic polyps in conjunction with CT Colonography; and the TotalLook MammoAdvantage system, a mammography specific digitizer. The company sells its products to hospitals, ambulatory care centers, and free standing radiation oncology facilities. It sells its products directly, as well as through various original equipment manufacturer partners, distributors, and resellers worldwide. The company was founded in 1984 and is headquartered in Nashua, New Hampshire.
Medicine Health Cancer Imaging Cancers Radiation Breast Cancer Medical Imaging Healthcare Professionals Radiation Therapy CAD Workflow Solutions Cancer Screening MRI Skin Cancer Mammography Breast Imaging Endometrial Cancer Picture Archiving And Communication System

Is ICAD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 15.31
52 Week Low 5.51
Average Volume 346,174
200-Day Moving Average 9.48
50-Day Moving Average 10.45
20-Day Moving Average 9.92
10-Day Moving Average 9.75
Average True Range 0.67
ADX 16.16
+DI 25.56
-DI 17.25
Chandelier Exit (Long, 3 ATRs ) 9.11
Chandelier Exit (Short, 3 ATRs ) 10.32
Upper Bollinger Band 10.84
Lower Bollinger Band 9.00
Percent B (%b) 0.76
BandWidth 18.49
MACD Line -0.04
MACD Signal Line -0.16
MACD Histogram 0.1239
Fundamentals Value
Market Cap 172.59 Million
Num Shares 16.6 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -18.57
Price-to-Sales 2.98
Price-to-Book 3.16
PEG Ratio -0.58
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.12
Resistance 3 (R3) 11.09 10.81 11.00
Resistance 2 (R2) 10.81 10.63 10.83 10.96
Resistance 1 (R1) 10.61 10.52 10.47 10.64 10.92
Pivot Point 10.33 10.33 10.27 10.35 10.33
Support 1 (S1) 10.13 10.15 9.99 10.16 9.88
Support 2 (S2) 9.85 10.04 9.87 9.84
Support 3 (S3) 9.65 9.85 9.80
Support 4 (S4) 9.68